WO2000001425A1 - Wound dressings and materials suitable for use therein - Google Patents
Wound dressings and materials suitable for use therein Download PDFInfo
- Publication number
- WO2000001425A1 WO2000001425A1 PCT/GB1999/002093 GB9902093W WO0001425A1 WO 2000001425 A1 WO2000001425 A1 WO 2000001425A1 GB 9902093 W GB9902093 W GB 9902093W WO 0001425 A1 WO0001425 A1 WO 0001425A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fabric
- cellulose
- fibre
- water
- carboxymethylated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/02—Alkyl or cycloalkyl ethers
- C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
- C08B11/10—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals
- C08B11/12—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals substituted with carboxylic radicals, e.g. carboxymethylcellulose [CMC]
Definitions
- This invention relates to wound dressings, in particular to dressings in fabric form and other forms suitable as contact layers for exuding wounds, and to methods for the manufacture of such dressings and of materials for use therein.
- Commonly-used wound dressings include foams, sponges and fibre-based materials such as gauzes and waddings, for example of cotton or viscose rayon. Such fibre-based materials tend to adhere to the wound surface and are accordingly difficult to remove, after use, in one piece and without causing trauma to the patient.
- Known wound dressings also include advanced dressings based for example on alginates or on various kinds of hydrocolloids or hydrogels, but such dressings are relatively expensive and are accordingly used in general only when clinical needs so recommend.
- wound dressings which possess at least some degree of absorbency, but which are sufficiently non-adherent that they are capable of being removed from a wound in a single piece without shedding fibre fragments and without trauma to the patient, and which are inexpensive in comparison with advanced dressings.
- WO-A-94/16746 discloses a wound dressing in which the wound- contacting surface comprises carboxymethylcellulose (CMC) filaments capable of absorbing at least 15 times, preferably at least 25 times, their own weight of 0.9% by weight aqueous saline solution (as measured by a defined free-swell absorbency test) to form a swollen transparent gel, the thusly-swollen dressing retaining sufficient fibrous character to be removed as a coherent dressing from a wound.
- the degree of substitution (D.S.) of the CMC filaments is preferably at least 0.15, more preferably from 0.2 to 0.5, although it may be up to for example 1.0.
- the CMC filaments may generally be prepared by reacting cellulose filaments in the presence of strong alkali with chloracetic acid or a salt thereof.
- the cellulose filaments may be viscose rayon, cuprammonium rayon or cotton, but they are preferably solvent-spun and may accordingly be lyocell .
- WO-A- 95/19795 discloses a wound dressing which comprises a blend of textile fibres and gel-forming fibres.
- the textile fibres may be natural or synthetic but are preferably cellulosic fibres such as viscose rayon or cotton.
- the gel-forming fibres may for example be carboxymethylcellulose or alginate fibres.
- the gel-forming fibres can be of the type which retain their structural integrity on absorption of exudate or can be of the type which lose their fibrous form and become a structureless gel or a solution on absorption of exudate.
- the absorbency of the gel-forming fibre is desirably at least 2 g/g of 0.9% saline solution, preferably at least 15 g/g, more preferably between 25 and 50 g/g.
- the D.S. of a carboxymethylcellulose fibre is desirably at least 0.05, preferably at least 0.2, more preferably between 0.3 and 0.5.
- Such dressings are said to have the advantage that the fibres they contain are not engulfed by new tissue formed during the healing process, so that they can be removed without causing wound injury.
- a process for the manufacture of a wound dressing comprising the step of carboxymethylating a cellulosic fabric such that the absorbency (as defined hereinafter) of the fabric after carboxymethylation is no more than 3 g/g, preferably no more than 2.5 g/g, further preferably no more than 2 g/g or 1 g/g, greater than the absorbency (as defined hereinafter) of the fabric before carboxymethylation and such that the degree of substitution of cellulose by carboxymethyl groups in the carboxymethylated fabric measured by IR spectroscopy (as defined hereinafter) is m the range from 0.12 to 0.35, preferacly from 0.2 to 0.3.
- the invention also includes wound dressings which comprise 5 such carboxymethylated fabric .
- absorbency of the fabric before and arter treatment, we mean the absorbency figures assessed by the method described m British Pharmacopoeia 1993, Addendum 10 1995, page 1706 for Algmate Dressings, but with substitution of the fabric under test for the algmate specified therein, which method yields absorbency m terms of weight per unit area, and then converted to absorbency m terms o weight ratio (g/g) .
- the cellulosic fabric preferably consists solely cf cellulosic fibre but may contain a proportion ot non cellulosic textile fibre or of gel-forming fibre.
- 'ne cellulosic fibre is of known kind and may be a natural fibre such as cotton or a manmade fibre such as lyocell or viscose
- 25 fabric may comprise continuous filament yarn and/ox staple fibre
- a fabric of continuous filament yarn may be preferred, on the ground that such fabrics are less liable to shed fibre fragments on handling or on removal from a wound.
- 30 dressings according to the invention composed of staple fibres have a low tendency to shed fragments.
- the cellulosic fabric s of known kind and may oe made m known manner.
- the basis weight of the fabric is generally m the range from 30 to 250 g/m 2 .
- the cellulosic fabric may
- a nonwoven fabi'ic should be of sufficiently robust construction - for example, having sufficiently high fibre entanglement - that the carboxymethylated fabric after absorption of aqueous liquors possesses sufficient mechanical integrity to permit it to be removed from a wound in a single piece.
- the carboxymethylation step is generally performed by- contacting the fabric with strong alkali, for example sodium hydroxide, and a carboxymethylating agent such as chloracetic acid or a salt thereof such as the sodium salt. These reagents may be applied to the fabric separately or together.
- the reaction is conveniently performed in an aqueous system.
- This system preferably comprises a water- miscible organic solvent such as ethanol or industrial methylated spirit, in order to suppress swelling and dissolution of carboxymethylated cellulose.
- WO-A-94/16746 for general discussion of the carboxymethylation reaction.
- a preferred method of performing such a carboxymethylation step is as follows, and such a method of carboxymethylating a fibre of cellulose II forms a second aspect of the invention.
- Regenerated or reconstituted cellulose fibre (cellulose II) is contacted with a solution containing from 4 to 8 percent by weight sodium hydroxide, the amount of sodium chloracetate necessary to achieve the desired degree of substitution, from 50 to 60 percent by weight water, and the balance ethanol.
- the solution is considered to consist of the substances applied to the fibre and any moisture introduced with the fibre and/or ethanol.
- the solution may contain a small proportion of methanol if industrial methylated spirit is used as the source of ethanol.
- the method is preferably performed at from 40 to 80°C, more preferably from 50 to 60°C.
- the method is preferably performed for from 20 to 90 min. , more preferably from 30 to 60 min. Ethanol may be substituted by another alcohol of the C ⁇ group.
- the method of the second aspect of the invention may be performed on loose fibre, yarn or fabric.
- the large majority of the carboxymethyl groups in the carboxymethylated material according to the invention is located in the amorphous regions and that only a small minority is located in the crystalline regions. It is thought that the crystalline regions act as entanglement points in the polymeric structure, thus advantageously providing a fabric with good wet strength and also suppressing dissolution of carboxymethylcellulose. It is also thought that the relatively low absorbency is in part a consequence of this phenomenon; but it is one which does not detract from performance in the intended use.
- a carboxymethylated cellulose article wherein the degree of substitution of cellulose groups measured by IR spectroscopy (as defined hereinafter) is in the range from 0.12 to 0.35, preferably from 0.15 to 0.3 or from 0.2 to 0.3, and wherein the degree of crystallinity measured by NMR (as defined hereinafter) is in the range from 10 to 70 percent, preferably from 15 to 60 or from 20 to 65 percent, more preferably from 30 to 55 percent.
- the article may take the form of a film, including a perforated film, a foam or sponge, or preferably a fibre.
- the invention also includes fabrics and dressings which comprise such articles. Wound dressings which comprise fibre according to the third aspect of the invention may conveniently be made by the process and method of the first and second aspects of the invention.
- the 13 C NMR spectrum of cellulose contains features in the 80-90 ppm region attributable to crystalline cellulose
- a method of carboxymethylating an article of cellulose II wherein the article is contacted with a solution containing sodium hydroxide, sodium chloracetate, ethanol and water, characterised in that the weight ratio of sodium hydroxide to water is in the range from 0.095 to 0.115, preferably from 0.10 to 0.11, and in that the weight ratio of cellulose to water is in the range from 0.22 to 0.28, preferably from 0.24 to 0.26.
- the method is preferably performed at from 40 to 80 °C, more preferably from 50 to 60 °C.
- the method is preferably performed for from 20 to 90 min. , more preferably from 30 to 60 min.
- the sodium hydroxide concentration may correspond to a swelling maximum for cellulose.
- the article may be for example a fibre, an article containing a fibre such as a woven, knitted or nonwoven fabric, a film or a sponge.
- the amount of sodium chloracetate is chosen so as to achieve the desired degree of substitution.
- the amount of ethanol is chosen so as to achieve a suitable liquor-to-goods ratio. It will be appreciated that a high liquor-to-goods ratio is desirable for voluminous articles such as sponges and bulky nonwovens .
- Articles made by the method of the fourth aspect of the invention are useful in the manufacture of wound dressings, and the invention includes such dressings.
- the method of the fourth aspect of the invention can be used to make articles according to the third aspect of the invention.
- a carboxymethylated fibre according to the third aspect of the invention made from lyocell or a carboxymethylated fibre made by the methods of the first, second or fourth aspects of the invention from lyocell may have an absorbency of at least 8 g/g of 0.9% (by weight) saline solution, as measured by the free swell method of WO-A- 93/12275 , and a tenacity of at least 10 cN/tex.
- a fabric dressing according to the invention Upon wetting, a fabric dressing according to the invention retains its textile character, swells to a moderate degree and exhibits a desirable surface slipperiness or "gel feel" .
- a fabric dressing according to the invention may exhibit a lower absorbency than that of the cellulosic fabric, but that nevertheless when wetted it may exhibit a desirable degree of slipperiness (lubricity) when rubbed between the fingers.
- a desirable degree of slipperiness in the present context is somewhat comparable to that observed when fingers wetted with weak soap solution or with dilute aqueous alkali (e.g. 0.01-O.lM NaOH) are rubbed together.
- a dressing according to the invention which consists solely of carboxymethylated cellulose fibres has the advantage that it presents a homogeneous surface to the wound.
- the dressings according to the invention may include or be used in conjunction with a secondary or backing layer of known type, for example an absorbent layer or a layer designed to maintain the wound environment, for example by keeping the wound moist.
- a backing layer may be affixed before or after the carboxymethylation step.
- the dressings of the invention may comprise a backing layer of a fusible thermoplastic fibre such as polypropylene, to permit thermal bonding to a further backing layer.
- a fusible backing layer may be incorporated in a fabric dressing by processes known in the manufacture of nonwoven fabrics such as needle bonding, stitchbonding and preferably hydroentanglement .
- the dressings according to the invention may be medicated.
- the dressings of the invention may comprise two or more plies of the fabric of the invention.
- the dressings according to the invention find use particularly as coverings for exuding wounds, more particularly for chronic wounds.
- the degree of substitution of cellulose by carboxymethyl groups was measured by IR spectroscopy as follows. IR spectra were recorded of viscose rayon (D.S. zero), of commercial samples of CMC of known D.S. (0.3, 0.6, 0.85 and 1.05), of a fabric made according to WO-A-94/ 16746 (D.S. 0.4), and of fabrics in accordance with the invention. Analysis of the spectra of the samples of known D.S. yielded the linear equation:
- D.S. 0.678 * I + 0.05
- the spectra of the fabric according to WO-A-94/16746 and of fabrics of the invention exhibited differences in detail: in particular, the shapes of the broad peak in the O-H stretch region (3500-3000 cm “1 ) differed, and the C-0 stretch region (1200-1000 cm “1 ) of the fabric of the invention exhibited additional features. These differences could be seen most clearly from second-derivative spectra.
- the fabrics of the invention derived from rayon and lyocell exhibited sharp peaks at 3445 and 3480 cm "1 , attributable to crystalline cellulose II, whereas the sample according to WO-A-94/16746 did not.
- the degree of crystallinity of carboxymethylated cellulose was measured by NMR spectroscopy as follows. Solid state 1 C NMR spectra were obtained at 75 MHz using a Bruker AC3000 (Trade Mark) spectrometer. Measurements were performed on samples packed into 7 mm zirconia rotors using proton-to-carbon cross-polarisation and magic angle spinning
- CPMAS CPMAS
- Conditions employed were a magic angle spinning speed of 5.0-5.5 kHz and a 90° proton preparation pulse followed by 2 ms contact time with a pulse recycle time of 3 s. Typically, a thousand scans were acquired on each sample; this is a preferred minimum number. Intensity over the range 50 to 120 ppm was integrated, with background correction. Percentage crystallinity was calculated using the formula 100(S-R)/S, where S is the integrated intensity of the sample under test and R is the integrated intensity of a reference sample of CMC prepared according to Example 1 of WO-A-94/16746.
- results on articles according to the invention are consistent with substantially uniform carboxymethylation in the amorphous regions but little or no carboxymethylation in the crystalline regions.
- results on the fabric of WO-A-94/16746 are consistent with substantially uniform carboxymethylation of the whole fibre.
- Lyocell staple fibre was supplied by Courtaulds pic under the Trade Mark COURTAULDS LYOCELL and is now available from the same entity under its new name Akzo Nobel UK
- the vessel is then replaced in the waterbath for ten minutes with agitation.
- the liquor is then discarded.
- the fabric is placed in a crystallising dish and a first wash liquor is added; the fabric and liquor are then transferred into the reaction vessel in the waterbath for washing with hot wash liquor.
- the fabric is treated in similar manner with a second wash liquor and with a final wash liquor containing soft finish, after which it is set aside to dry at room temperature.
- Methods I and II are given in Table 1:
- the method referred to below as II* is method II, but with the temperature in the reaction step being 70 °C.
- the CMC sample was prepared as follows. Air-dry lyocell fibre, an aqueous solution of sodium hydroxide, ethanol, and an aqueous solution of sodium chloracetate were charged into a reactor to yield a mixture containing bone-dry cellulose (9 kg), sodium hydroxide (3.8 kg), sodium monochloracetate (5.7 kg), water (24.3 kg, including water introduced with the fibre) and ethanol (26.1 kg) . Thus, the NaOH/water ratio was 0.156 and the cellulose/water ratio was 0.370. The reactor was heated at 70 °C for 65 min. Acetic acid (7 1) was added to the mixture and the temperature was maintained at 70°C for 10 min. Excess liquor was removed by blowing down with nitrogen.
- the fibre was washed with a solution of citric acid (0.3 kg) in water (23 kg) and ethanol (30 kg) at 70 °C for 10 min. Excess liquor was removed by blowing down with nitrogen. The washing and blowing-down stages were repeated. The fibre was then washed with a solution of soft finish (0.3 kg) in water (6 kg) and ethanol (48 kg) at 70 °C for 10 min. Excess liquor was removed by blowing down with nitrogen, and the CMC fibre was dried in an air dryer.
- a laminate was made by laying-up a web of lyocell staple fibre (33 g/m 2 ) and a nonwoven polypropylene backing scrim (7.5 g/m 2 ) followed by hydroentangling (6 heads: pressure 2x40 and 4x60 bar) from the lyocell side.
- the lyocell fibre in the resulting laminate was carboxymethylated by method II of Example 1.
- the polypropylene side of the carboxymethylated laminate was readily adhered to a nonwoven fabric backing of viscose staple fibre (330 g/m 2 ) by application of heat using a domestic iron.
- Cellulose sponge (25 g,- in the form of a sheet roughly 5 mm thick, as used for domestic cleaning purposes; bulk density
- the liquor was discarded, and the sponge was washed with a solution of 0.8 g citric acid in a mixture of 84 ml water and 137 ml IMS.
- the wash- liquor was discarded and the washing step repeated.
- the wash liquor was again discarded and the sponge washed with a mixture of 0.85 g Tween finish, 25 ml water and 265 ml IMS.
- the liquor was discarded and the sponge washed with a mixture of 30 g glycerol, 30 ml water and 40 ml IMS.
- the liquor was discarded and the sponge dried at ambient temperature .
- the glycerol served as softening agent to prevent the sponge becoming hard and board- like on drying.
- reaction conditions differ from those of Example 1 essentially in the use of greater liquid volumes to cater for the low bulk density of the sponge. Reaction volumes may be reduced if a compressed sponge is used.
- the "gel feel" of the sponge before and after carboxymethylation was 0 and 5 respectively.
- the D.S. of the carboxymethylated sponge was 0.30 and the crystallinity 30%.
- Example 1 The treatment solution contained 19.1 g NaOH,
- a roll of fabric A of Example 1 (1250 g air-dry; 10% moisture; 17 cm diameter x 22 cm long) was carboxymethylated in a kier according to the general procedure of Example 1.
- the treatment solution contained 478.1 g NaOH, 717.2 g sodium chloracetate, 4241.8 g IMS and 4275 g water
- the NaOH/water ratio was 0.112 and the cellulose/water ratio was 0.263.
- the reaction was conducted for 40 min at 70 °C.
- the "gel feel" of the resulting product was 6, the D.S. 0.23 and the crystallinity 24%.
- a sample of a bulky apertured nonwoven fabric of lyocell fibre (50 g air-dry; 10% moisture; basis weight 65 g/m 2 ) was carboxymethylated according to the general procedure of Example 1.
- the treatment solution contained 19.1 g NaOH, 28.7 g sodium chloracetate, 231.2 g IMS and 171.0 g water (including moisture from the fabric).
- the NaOH/water ratio was 0.112 and the cellulose/water ratio was 0.263.
- the reaction was conducted for 30 min at 65°C.
- the "gel feel" of the resulting product was 5, the D.S. 0.31 and the crystallinity 26%.
- Example 8 A roll of the fabric used in Example 8 (4.50 kg air-dry; 39 cm diameter x 28 cm long) was carboxymethylated in a Icier according to the general procedure of Example 1.
- the treatment solution contained 1.72 kg NaOH, 2.58 kg sodium chloracetate, 44.89 kg IMS and 15.77 kg water (including moisture from the fabric) .
- the NaOH/water ratio was 0.109 and the cellulose/water ratio was 0.257.
- the reaction was conducted for 30 min at 60 °C.
- the "gel feel" of the resulting product was 4, the D.S. at the outside and inside of the roll was 0.18 and 0.17 respectively and the crystallinity at the outside and inside of the roll was 28% and 31% respectively.
- a roll of cotton gauze (23 g/m 2 ; 7.50 kg air-dry, 6.75 kg bone-dry) (cellulose I) was carboxymethylated in a kier according to the general procedure of Example 1.
- the treatment solution contained 2.87 kg NaOH, 4.30 kg sodium chloracetate, 19.60 kg IMS and 18.23 kg water (including moisture from the fabric) .
- the NaOH/water ratio was 0.157 and the cellulose/water ratio was 0.370.
- the reaction was conducted for 65 min at 70°C.
- the "gel feel" of the resulting product was 6, the D.S. ranged from 0.16 to 0.21, and the crystallinity was 42%.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/720,375 US6548730B1 (en) | 1998-07-01 | 1999-07-01 | Wound dressings and materials suitable for use therein |
AU46318/99A AU757461B2 (en) | 1998-07-01 | 1999-07-01 | Wound dressings and materials suitable for use therein |
JP2000557871A JP2002519153A (en) | 1998-07-01 | 1999-07-01 | Manufacture of wound dressings, their manufacture and materials suitable for their use |
EP99929527A EP1091770A1 (en) | 1998-07-01 | 1999-07-01 | Wound dressings and materials suitable for use therein |
CA002335563A CA2335563C (en) | 1998-07-01 | 1999-07-01 | Wound dressings and materials suitable for use therein |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9814273.0 | 1998-07-01 | ||
GBGB9814273.0A GB9814273D0 (en) | 1998-07-01 | 1998-07-01 | Wound dressings and their manufacture |
GB9824667.1 | 1998-11-10 | ||
GBGB9824667.1A GB9824667D0 (en) | 1998-11-10 | 1998-11-10 | Wound dressings and manufacture of the same |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000001425A1 true WO2000001425A1 (en) | 2000-01-13 |
Family
ID=26313957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1999/002093 WO2000001425A1 (en) | 1998-07-01 | 1999-07-01 | Wound dressings and materials suitable for use therein |
Country Status (9)
Country | Link |
---|---|
US (1) | US6548730B1 (en) |
EP (2) | EP2036581B1 (en) |
JP (2) | JP2002519153A (en) |
CN (1) | CN1204928C (en) |
AU (1) | AU757461B2 (en) |
CA (1) | CA2335563C (en) |
DK (1) | DK2036581T3 (en) |
ES (1) | ES2388688T3 (en) |
WO (1) | WO2000001425A1 (en) |
Cited By (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002003898A1 (en) * | 2000-07-12 | 2002-01-17 | Bristol-Myers Squibb Company | Multi layered wound dressing |
WO2003092755A1 (en) * | 2002-05-03 | 2003-11-13 | Acordis Speciality Fibres Limited | Carboxymethylated cellulosic wound dressing |
WO2004062701A1 (en) * | 2003-01-10 | 2004-07-29 | Bristol-Myers Squibb Company | Wound dressing |
WO2004089265A2 (en) * | 2003-04-10 | 2004-10-21 | Bristol-Myers Squibb Company | Wound dressing |
WO2005079718A1 (en) * | 2004-02-13 | 2005-09-01 | Bristol-Myers Squibb Company | Multi layered wound dressing |
WO2007003905A1 (en) | 2005-07-01 | 2007-01-11 | Bristol-Myers Squibb Company | Wound dressing material |
WO2007003900A3 (en) * | 2005-07-01 | 2007-07-12 | Bristol Myers Squibb Co | Carboxymethylated cellulosic wound dressing garment |
WO2008037082A1 (en) | 2006-09-25 | 2008-04-03 | Archer-Daniels-Midland Company | Superabsorbent surface-treated carboxyalkylated polysaccharides and process for producing same |
WO2008075219A2 (en) * | 2006-12-15 | 2008-06-26 | Kimberly-Clark Worldwide, Inc. | Absorbent fiber with a low absorbent capacity and slow absorption rate |
US7455911B2 (en) | 2002-10-25 | 2008-11-25 | Paul Hartman Ag | Anti-adhesive coating for treating bandages |
WO2011012424A1 (en) | 2009-07-31 | 2011-02-03 | Kelheim Fibres Gmbh | Regenerated cellulose fibre |
WO2013017890A1 (en) | 2011-08-04 | 2013-02-07 | Convatec Technologies Inc | A dressing |
US8404921B2 (en) | 2007-06-06 | 2013-03-26 | Convatec Technologies, Inc. | Wound dressing |
WO2013079947A1 (en) | 2011-12-01 | 2013-06-06 | Convatec Technologies Inc | Wound dressing for use in vacuum therapy |
WO2014009488A2 (en) | 2012-07-13 | 2014-01-16 | Laboratoires Urgo | Dressing having the controlled release of active agents |
US8728513B2 (en) | 2000-09-21 | 2014-05-20 | Convatec Technologies Inc. | Silver containing wound dressing |
WO2014147339A1 (en) | 2013-03-20 | 2014-09-25 | Laboratoires Urgo | Dressing having an adhesive peripheral edge with an undulating circumference |
EP2997981A4 (en) * | 2013-05-09 | 2016-06-08 | Asahi Kasei Fibers Corp | Medical material employing carboxymethyl cellulose |
WO2017153289A1 (en) | 2016-03-08 | 2017-09-14 | Urgo Recherche Innovation Et Developpement | Dressing suitable for sensitive skin |
WO2018011520A1 (en) | 2016-07-12 | 2018-01-18 | Urgo Recherche Innovation Et Developpement | Dressing enabling the controlled and prolonged release of metformin |
DE102017006025A1 (en) | 2017-06-27 | 2018-12-27 | Carl Freudenberg Kg | Hydrogel-forming multicomponent fiber |
US10195087B2 (en) | 2009-04-08 | 2019-02-05 | Brightwake Limited | Absorbent wound dressing for wrapping around jointed limbs |
US10350326B2 (en) | 2012-05-31 | 2019-07-16 | Convatec Technologies Inc. | Wound dressing |
US10687985B2 (en) | 2008-05-08 | 2020-06-23 | Convatec Technologies, Inc. | Wound dressing |
WO2021130474A1 (en) | 2019-12-27 | 2021-07-01 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy system |
WO2021130475A1 (en) | 2019-12-27 | 2021-07-01 | Convatec Limited | Negative pressure wound dressing |
WO2021152310A1 (en) | 2020-01-29 | 2021-08-05 | Convatec Limited | A pump assembly and a wound therapy apparatus |
WO2021165701A1 (en) | 2020-02-20 | 2021-08-26 | Convatec Limited | A method and control system for a wound therapy apparatus |
WO2021165696A1 (en) | 2020-02-20 | 2021-08-26 | Convatec Limited | A wound dressing and a wound therapy apparatus |
GB202110651D0 (en) | 2021-07-23 | 2021-09-08 | Convatec Ltd | Kit for use with a selectively configurable wound dressing |
GB202110650D0 (en) | 2021-07-23 | 2021-09-08 | Convatec Ltd | Port with piercing means |
GB202110648D0 (en) | 2021-07-23 | 2021-09-08 | Convatec Ltd | A selectively configurable wound dressing |
GB202110649D0 (en) | 2021-07-23 | 2021-09-08 | Convatec Ltd | A selectively configurable wound dressing |
GB202110652D0 (en) | 2021-07-23 | 2021-09-08 | Convatec Ltd | A selectively configurable wound dressing |
WO2021186188A1 (en) | 2020-03-20 | 2021-09-23 | Convatec Limited | Debridement composition |
EP4035636A1 (en) | 2016-05-09 | 2022-08-03 | ConvaTec Technologies Inc. | Negative pressure wound dressing management system |
US11458044B2 (en) | 2008-09-29 | 2022-10-04 | Convatec Technologies Inc. | Wound dressing |
RU2791792C1 (en) * | 2022-12-09 | 2023-03-13 | Федеральное государственное бюджетное учреждение науки Институт химии твердого тела механохимии Сибирского отделения Российской академии наук | Method for obtaining a non-gelling powdered sodium carboxymethyl cellulose product from vegetable raw materials, the obtained product and its application |
WO2023152406A2 (en) | 2022-06-16 | 2023-08-17 | Ampa Medical Aps | An absorbent insert ostomy device for insertion through an ostomy of a human being |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100906901B1 (en) | 2001-09-12 | 2009-07-08 | 콘바텍 리미티드 | Antibacterial Wound Dressing |
GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
WO2005104661A2 (en) * | 2004-05-05 | 2005-11-10 | Ofer Spottheim | Skin lesion protector |
US8951551B2 (en) * | 2005-08-31 | 2015-02-10 | Board Of Regents, The University Of Texas System | Multiribbon nanocellulose as a matrix for wound healing |
GB0525504D0 (en) | 2005-12-14 | 2006-01-25 | Bristol Myers Squibb Co | Antimicrobial composition |
GB2439928A (en) * | 2006-07-13 | 2008-01-16 | Ethicon Inc | Hydrogel wound dressings exhibiting reduced fiber losses |
JP5265124B2 (en) * | 2006-08-01 | 2013-08-14 | 日本製紙株式会社 | Amorphous cellulose derivative |
JP2009120716A (en) * | 2007-11-14 | 2009-06-04 | Kao Corp | Manufacturing method of hydroxyethyl cellulose |
ES2555204T3 (en) | 2007-11-21 | 2015-12-29 | T.J. Smith & Nephew Limited | Suction and bandage device |
AU2011278462A1 (en) | 2010-07-12 | 2013-01-10 | Akzo Nobel Chemicals International B.V. | Cellulosic fibre composition |
GB201020236D0 (en) | 2010-11-30 | 2011-01-12 | Convatec Technologies Inc | A composition for detecting biofilms on viable tissues |
CN103120802B (en) * | 2012-07-26 | 2015-02-25 | 佛山市优特医疗科技有限公司 | Soluble hemostatic gauze and preparation methods thereof |
US9656000B2 (en) * | 2012-10-18 | 2017-05-23 | International Business Machines Corporation | Wound dressing |
CN105008611A (en) | 2012-12-20 | 2015-10-28 | 康沃特克科技公司 | Processing of chemically modified cellulosic fibres |
CN103041437A (en) * | 2012-12-25 | 2013-04-17 | 武汉纺织大学 | High-intensity high-hydroscopicity medical dressing containing carboxymethyl cellulose and preparation method thereof |
CN103074699A (en) * | 2012-12-28 | 2013-05-01 | 佛山市优特医疗科技有限公司 | Chemically-modified sea silk fiber, wound dressing made from same, and preparation method of same |
JP2015070944A (en) * | 2013-10-03 | 2015-04-16 | 旭化成せんい株式会社 | Carboxymethyl cellulose fiber sheet-like structure, and manufacturing method of the same |
GB201409252D0 (en) * | 2014-05-23 | 2014-07-09 | First Water Ltd | Apertured hydrogel compositions and wound dressings |
AU2015294612B2 (en) | 2014-07-24 | 2019-07-11 | Arthrocare Corporation | Resilient polysaccharide foams and uses thereof |
US9610379B2 (en) | 2015-01-23 | 2017-04-04 | Fpinnovations | Absorbent fibres produced from low-substituted carboxymethyl cellulose and the process thereof |
CN108113800B (en) * | 2017-12-20 | 2021-08-10 | 健尔康医疗科技股份有限公司 | Elastic bandage |
CN110357973A (en) * | 2018-04-10 | 2019-10-22 | 上海长光企业发展有限公司 | A kind of sodium carboxymethylcellulose and its preparation method and application |
CN108774875B (en) * | 2018-07-03 | 2021-03-30 | 苏州恒瑞迪生医疗科技有限公司 | Medical hydrophilic fiber dressing |
CN116695438B (en) * | 2023-08-08 | 2023-10-20 | 潍坊广栗新材料科技有限公司 | Preparation method of carboxymethyl cellulose long fiber with good hydrophilicity |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4256877A (en) * | 1976-12-21 | 1981-03-17 | Sca Development Aktiebolag | Method of manufacturing cellulose derivative |
US4405324A (en) * | 1981-08-24 | 1983-09-20 | Morca, Inc. | Absorbent cellulosic structures |
US4579943A (en) * | 1983-10-31 | 1986-04-01 | Asahi Kasei Kogyo Kabushiki Kaisha | Cellulose derivative excellent in liquid absorbing property, process for preparing same and structure containing same |
WO1993012275A1 (en) * | 1991-12-10 | 1993-06-24 | Courtaulds Plc | Cellulosic fibres |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4923454A (en) * | 1988-01-20 | 1990-05-08 | The Procter & Gamble Company | Microfiber-containing absorbent structures and absorbent articles |
US5206205A (en) * | 1991-08-15 | 1993-04-27 | Kimberly-Clark Corporation | Thermal treatment of superabsorbents to enhance their rate of absorbency under load |
WO1994016746A1 (en) * | 1993-01-22 | 1994-08-04 | Courtaulds Plc | Wound dressings |
GB9301258D0 (en) * | 1993-01-22 | 1993-03-17 | Courtaulds Plc | Use of absorbent fibre |
TW295607B (en) * | 1993-05-24 | 1997-01-11 | Courtaulds Fibres Holdings Ltd | |
FR2706309B1 (en) | 1993-06-17 | 1995-10-06 | Sofamor | Instrument for surgical treatment of an intervertebral disc by the anterior route. |
GB9400994D0 (en) | 1994-01-20 | 1994-03-16 | Bristol Myers Squibb Co | Wound dressing |
GB9618573D0 (en) * | 1996-09-05 | 1996-10-16 | Courtaulds Fibres Holdings Ltd | Wound dressings and manufacture thereof |
-
1999
- 1999-07-01 EP EP08017432A patent/EP2036581B1/en not_active Expired - Lifetime
- 1999-07-01 AU AU46318/99A patent/AU757461B2/en not_active Expired
- 1999-07-01 ES ES08017432T patent/ES2388688T3/en not_active Expired - Lifetime
- 1999-07-01 JP JP2000557871A patent/JP2002519153A/en not_active Withdrawn
- 1999-07-01 US US09/720,375 patent/US6548730B1/en not_active Expired - Lifetime
- 1999-07-01 CN CNB998078115A patent/CN1204928C/en not_active Expired - Lifetime
- 1999-07-01 CA CA002335563A patent/CA2335563C/en not_active Expired - Lifetime
- 1999-07-01 EP EP99929527A patent/EP1091770A1/en not_active Ceased
- 1999-07-01 DK DK08017432.9T patent/DK2036581T3/en active
- 1999-07-01 WO PCT/GB1999/002093 patent/WO2000001425A1/en active IP Right Grant
-
2011
- 2011-09-16 JP JP2011203050A patent/JP5612551B2/en not_active Expired - Lifetime
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4256877A (en) * | 1976-12-21 | 1981-03-17 | Sca Development Aktiebolag | Method of manufacturing cellulose derivative |
US4405324A (en) * | 1981-08-24 | 1983-09-20 | Morca, Inc. | Absorbent cellulosic structures |
US4579943A (en) * | 1983-10-31 | 1986-04-01 | Asahi Kasei Kogyo Kabushiki Kaisha | Cellulose derivative excellent in liquid absorbing property, process for preparing same and structure containing same |
WO1993012275A1 (en) * | 1991-12-10 | 1993-06-24 | Courtaulds Plc | Cellulosic fibres |
Cited By (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2370781A (en) * | 2000-07-12 | 2002-07-10 | Bristol Myers Squibb Co | Multi layered wound dressing |
US7803980B2 (en) | 2000-07-12 | 2010-09-28 | Convatec Technologies Inc. | Multi-layered wound dressing |
GB2370781B (en) * | 2000-07-12 | 2004-05-12 | Bristol Myers Squibb Co | Multi layered wound dressing |
US6793645B2 (en) | 2000-07-12 | 2004-09-21 | Bristol-Myers Squibb Company | Multi-layered wound dressing |
WO2002003898A1 (en) * | 2000-07-12 | 2002-01-17 | Bristol-Myers Squibb Company | Multi layered wound dressing |
US10010647B2 (en) | 2000-09-21 | 2018-07-03 | Convatec Technologies Inc. | Silver containing wound dressing |
US8728513B2 (en) | 2000-09-21 | 2014-05-20 | Convatec Technologies Inc. | Silver containing wound dressing |
US9066989B2 (en) | 2000-09-21 | 2015-06-30 | Convatec Technologies Inc. | Silver containing wound dressing |
US9345805B2 (en) | 2000-09-21 | 2016-05-24 | Convatec Technologies Inc. | Silver containing wound dressing |
US10391197B2 (en) | 2000-09-21 | 2019-08-27 | Convatec Technologies Inc. | Silver containing wound dressing |
CN100342919C (en) * | 2002-05-03 | 2007-10-17 | 阿科迪斯特殊纤维有限公司 | Carboxymethylated cellulosic wound dressing |
AU2003229983B2 (en) * | 2002-05-03 | 2009-01-22 | Acordis Speciality Fibres Limited | Carboxymethylated cellulosic wound dressing |
WO2003092755A1 (en) * | 2002-05-03 | 2003-11-13 | Acordis Speciality Fibres Limited | Carboxymethylated cellulosic wound dressing |
US7652189B2 (en) | 2002-05-03 | 2010-01-26 | Convatec Limited | Carboxymethylated cellulosic wound dressing |
US7455911B2 (en) | 2002-10-25 | 2008-11-25 | Paul Hartman Ag | Anti-adhesive coating for treating bandages |
US7759539B2 (en) | 2003-01-10 | 2010-07-20 | Convatec Technologies Inc. | Wound dressing |
WO2004062701A1 (en) * | 2003-01-10 | 2004-07-29 | Bristol-Myers Squibb Company | Wound dressing |
WO2004089265A3 (en) * | 2003-04-10 | 2005-01-20 | Bristol Myers Squibb Co | Wound dressing |
WO2004089265A2 (en) * | 2003-04-10 | 2004-10-21 | Bristol-Myers Squibb Company | Wound dressing |
AU2004228750B2 (en) * | 2003-04-10 | 2010-01-21 | Convatec Technologies Inc. | Wound dressing |
US7723559B2 (en) | 2003-04-10 | 2010-05-25 | Convatec Technologies Inc. | Wound dressing |
GB2429161B (en) * | 2004-02-13 | 2008-12-24 | Bristol Myers Squibb Co | Multi layered wound dressing |
GB2429161A (en) * | 2004-02-13 | 2007-02-21 | Bristol Myers Squibb Co | Multi layered wound dressing |
WO2005079718A1 (en) * | 2004-02-13 | 2005-09-01 | Bristol-Myers Squibb Company | Multi layered wound dressing |
US7759537B2 (en) | 2004-02-13 | 2010-07-20 | Convatec Technologies Inc. | Multi layered wound dressing |
US9326894B2 (en) | 2005-07-01 | 2016-05-03 | Convatec Technologies, Inc. | Wound dressing material |
US8110717B2 (en) | 2005-07-01 | 2012-02-07 | Convatec Technologies Inc. | Carboxymethylated cellulosic wound dressing garment |
WO2007003905A1 (en) | 2005-07-01 | 2007-01-11 | Bristol-Myers Squibb Company | Wound dressing material |
WO2007003900A3 (en) * | 2005-07-01 | 2007-07-12 | Bristol Myers Squibb Co | Carboxymethylated cellulosic wound dressing garment |
US8691266B2 (en) | 2005-07-01 | 2014-04-08 | Convatec Technologies, Inc. | Wound dressing material |
EP2066699A4 (en) * | 2006-09-25 | 2010-06-16 | Archer Daniels Midland Co | Superabsorbent surface-treated carboxyalkylated polysaccharides and process for producing same |
EP2066699A1 (en) * | 2006-09-25 | 2009-06-10 | Archer-Daniels-Midland Company | Superabsorbent surface-treated carboxyalkylated polysaccharides and process for producing same |
WO2008037082A1 (en) | 2006-09-25 | 2008-04-03 | Archer-Daniels-Midland Company | Superabsorbent surface-treated carboxyalkylated polysaccharides and process for producing same |
WO2008075219A2 (en) * | 2006-12-15 | 2008-06-26 | Kimberly-Clark Worldwide, Inc. | Absorbent fiber with a low absorbent capacity and slow absorption rate |
WO2008075219A3 (en) * | 2006-12-15 | 2009-01-29 | Kimberly Clark Co | Absorbent fiber with a low absorbent capacity and slow absorption rate |
US8404921B2 (en) | 2007-06-06 | 2013-03-26 | Convatec Technologies, Inc. | Wound dressing |
US10687985B2 (en) | 2008-05-08 | 2020-06-23 | Convatec Technologies, Inc. | Wound dressing |
US11458044B2 (en) | 2008-09-29 | 2022-10-04 | Convatec Technologies Inc. | Wound dressing |
US10195087B2 (en) | 2009-04-08 | 2019-02-05 | Brightwake Limited | Absorbent wound dressing for wrapping around jointed limbs |
US11452642B2 (en) | 2009-04-08 | 2022-09-27 | Brightwake Limited | Absorbent wound dressing for wrapping around jointed limbs |
US10047458B2 (en) | 2009-07-31 | 2018-08-14 | Kelheim Fibres Gmbh | Regenerated cellulose fiber |
WO2011012424A1 (en) | 2009-07-31 | 2011-02-03 | Kelheim Fibres Gmbh | Regenerated cellulose fibre |
US9279196B2 (en) | 2009-07-31 | 2016-03-08 | Kelheim Fibres Gmbh | Regenerated cellulose fiber |
US10751442B2 (en) | 2011-08-04 | 2020-08-25 | Convatec Technologies Inc. | Dressing |
WO2013017890A1 (en) | 2011-08-04 | 2013-02-07 | Convatec Technologies Inc | A dressing |
US10968543B2 (en) | 2011-12-01 | 2021-04-06 | Convatec Technologies Inc. | Wound dressing for use in vacuum therapy |
WO2013079947A1 (en) | 2011-12-01 | 2013-06-06 | Convatec Technologies Inc | Wound dressing for use in vacuum therapy |
EP3381478A1 (en) * | 2011-12-01 | 2018-10-03 | ConvaTec Technologies Inc. | Yarn comprising gel-forming fibres |
US9562305B2 (en) | 2011-12-01 | 2017-02-07 | Convatec Technologies Inc. | Yarn comprising gel-forming filaments or fibres |
AU2012343583B2 (en) * | 2011-12-01 | 2017-08-24 | Convatec Technologies Inc. | A yarn comprising gel-forming filaments or fibres |
WO2013079949A1 (en) | 2011-12-01 | 2013-06-06 | Convatec Technologies Inc. | A yarn comprising gel-forming filaments or fibres |
EP3750566A1 (en) | 2012-05-31 | 2020-12-16 | ConvaTec Technologies Inc. | Wound dressing |
US10350326B2 (en) | 2012-05-31 | 2019-07-16 | Convatec Technologies Inc. | Wound dressing |
WO2014009488A2 (en) | 2012-07-13 | 2014-01-16 | Laboratoires Urgo | Dressing having the controlled release of active agents |
US10172972B2 (en) | 2012-07-13 | 2019-01-08 | Laboratoires Urgo | Dressing having sustained release of active agents |
WO2014147339A1 (en) | 2013-03-20 | 2014-09-25 | Laboratoires Urgo | Dressing having an adhesive peripheral edge with an undulating circumference |
US9555149B2 (en) | 2013-05-09 | 2017-01-31 | Asahi Kasei Fibers Corporation | Medical material employing carboxymethyl cellulose |
EP2997981A4 (en) * | 2013-05-09 | 2016-06-08 | Asahi Kasei Fibers Corp | Medical material employing carboxymethyl cellulose |
WO2017153289A1 (en) | 2016-03-08 | 2017-09-14 | Urgo Recherche Innovation Et Developpement | Dressing suitable for sensitive skin |
EP4035636A1 (en) | 2016-05-09 | 2022-08-03 | ConvaTec Technologies Inc. | Negative pressure wound dressing management system |
WO2018011520A1 (en) | 2016-07-12 | 2018-01-18 | Urgo Recherche Innovation Et Developpement | Dressing enabling the controlled and prolonged release of metformin |
US11898274B2 (en) | 2017-06-27 | 2024-02-13 | Carl Freudenberg Kg | Hydrogel-forming multicomponent fiber |
WO2019002095A1 (en) | 2017-06-27 | 2019-01-03 | Carl Freudenberg Kg | Hydrogel-forming multicomponent fiber |
DE102017006025A1 (en) | 2017-06-27 | 2018-12-27 | Carl Freudenberg Kg | Hydrogel-forming multicomponent fiber |
WO2021130475A1 (en) | 2019-12-27 | 2021-07-01 | Convatec Limited | Negative pressure wound dressing |
WO2021130474A1 (en) | 2019-12-27 | 2021-07-01 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy system |
WO2021152310A1 (en) | 2020-01-29 | 2021-08-05 | Convatec Limited | A pump assembly and a wound therapy apparatus |
WO2021165701A1 (en) | 2020-02-20 | 2021-08-26 | Convatec Limited | A method and control system for a wound therapy apparatus |
WO2021165696A1 (en) | 2020-02-20 | 2021-08-26 | Convatec Limited | A wound dressing and a wound therapy apparatus |
WO2021186188A1 (en) | 2020-03-20 | 2021-09-23 | Convatec Limited | Debridement composition |
GB202110649D0 (en) | 2021-07-23 | 2021-09-08 | Convatec Ltd | A selectively configurable wound dressing |
GB202110652D0 (en) | 2021-07-23 | 2021-09-08 | Convatec Ltd | A selectively configurable wound dressing |
GB202110648D0 (en) | 2021-07-23 | 2021-09-08 | Convatec Ltd | A selectively configurable wound dressing |
GB202110650D0 (en) | 2021-07-23 | 2021-09-08 | Convatec Ltd | Port with piercing means |
WO2023002210A1 (en) | 2021-07-23 | 2023-01-26 | Convatec Limited | A selectively configurable wound dressing |
WO2023002212A1 (en) | 2021-07-23 | 2023-01-26 | Convatec Limited | A selectively configurable wound dressing |
WO2023002211A1 (en) | 2021-07-23 | 2023-01-26 | Convatec Limited | A selectively configurable wound dressing |
WO2023002225A1 (en) | 2021-07-23 | 2023-01-26 | Convatec Limited | Port with piercing means |
WO2023002213A1 (en) | 2021-07-23 | 2023-01-26 | Convatec Limited | Kit for use with a selectively configurable wound dressing |
GB202110651D0 (en) | 2021-07-23 | 2021-09-08 | Convatec Ltd | Kit for use with a selectively configurable wound dressing |
WO2023152406A2 (en) | 2022-06-16 | 2023-08-17 | Ampa Medical Aps | An absorbent insert ostomy device for insertion through an ostomy of a human being |
RU2791792C1 (en) * | 2022-12-09 | 2023-03-13 | Федеральное государственное бюджетное учреждение науки Институт химии твердого тела механохимии Сибирского отделения Российской академии наук | Method for obtaining a non-gelling powdered sodium carboxymethyl cellulose product from vegetable raw materials, the obtained product and its application |
Also Published As
Publication number | Publication date |
---|---|
CA2335563C (en) | 2009-04-14 |
CA2335563A1 (en) | 2000-01-13 |
CN1307489A (en) | 2001-08-08 |
ES2388688T3 (en) | 2012-10-17 |
JP2011255215A (en) | 2011-12-22 |
EP2036581B1 (en) | 2012-06-27 |
JP2002519153A (en) | 2002-07-02 |
US6548730B1 (en) | 2003-04-15 |
AU4631899A (en) | 2000-01-24 |
CN1204928C (en) | 2005-06-08 |
EP2036581A8 (en) | 2009-07-08 |
JP5612551B2 (en) | 2014-10-22 |
DK2036581T3 (en) | 2012-09-24 |
EP1091770A1 (en) | 2001-04-18 |
EP2036581A1 (en) | 2009-03-18 |
AU757461B2 (en) | 2003-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6548730B1 (en) | Wound dressings and materials suitable for use therein | |
JP4499669B2 (en) | Trauma bandage | |
KR100320636B1 (en) | Wound Protector | |
US5731083A (en) | Cellulosic fibres | |
CN102292112B (en) | Absorbent material | |
WO1995015342A1 (en) | Treatment of cellulose | |
KR102220102B1 (en) | Wound covering sheet | |
PT2036581E (en) | Wound dressings and materials suitable for use therein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99807811.5 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999929527 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09720375 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2335563 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 46318/99 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 1999929527 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 46318/99 Country of ref document: AU |